MRSA Reduction Campaign Toolkit
Staphylococcus aureus infections, which include methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-susceptible Staphylococcus Aureus (MSSA) are serious concerns in healthcare facilities and among patient populations. These infections can result in bacteremia or bloodstream infection, skin infection, surgical site infection, pneumonia, endocarditis and other serious infections.
Staphylococcus aureus infections can lead to increased length of hospital stay, increased morbidity and mortality, and increased use of hospital resources. THA is committed to reducing the burden of staph aureus among our patient population and works with hospitals to achieve this goal.
THA has developed a MRSA Reduction Toolkit which hospitals can use freely.
The purpose of this toolkit is to provide a repository of tools and resources to support healthcare teams in implementing evidence-based strategies to prevent hospital-onset Staphylococcus aureus.
Sources of Materials
The materials and tools included and referenced are from national agencies, including the Centers for Disease Control and Prevention (CDC), Agency for Healthcare Research and Quality (AHRQ), Society for Healthcare Epidemiology of America (SHEA), Health Research and Educational Trust Fund (HRET) and Healthcare Infection Control Practice Advisory Committee (HICPAC).
Materials highlight practical implementation of evidence-based strategies by some healthcare organizations. Users of this toolkit are encouraged to contact other organizations that have implemented these strategies to learn from their practical implementation.
While this toolkit provides evidence-based strategies, it is important to stress that every healthcare organization is unique. Thus, it may be necessary to develop and implement other strategies to address unique needs. One of the first steps in using this toolkit is to conduct a risk assessment. This risk assessment should be used to develop strategies that meet the needs of the organization.